FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approves a supplemental application for ACTOS (pioglitazone) from Takeda Pharmaceuticals America, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)

Snippet

SUPPL AP for ACTOS (PIOGLITAZONE)